CONTENT

To the Editor,

I read the article entitled “Adherence to Current Dyslipidemia Guideline in Patients Utilizing Statins According to Risk Groups and Gender Differences: The AIZANOI Study” published by Şen et al,¹ in the Anatolian Journal of Cardiology with great pleasure. In the mentioned study, the authors aimed to assess the adherence to the European Society of Cardiology dyslipidemia guidelines recommendations, the ratio of reaching target values according to risk groups, and the reasons for not reaching LDL-cholesterol (LDL-C) goals in patients already on statin therapy in the cardiology outpatient population. In this study, a very important issue concerning the daily practice of cardiology was discussed. However, there were some points I was curious about:

In conclusion, current guidelines should be taken into consideration in the management of dyslipidemia.

There is no conflict of interest regarding this scientific communication.

References

1. Şen T, Dinç Asarcıklı L, Güven S. Adherence to current dyslipidemia guideline in patients utilizing statins according to risk groups and gender differences: the AIZANOI study. Anatol J Cardiol. 2024;28(6):273-282.
2. Mach F, Baigent C, Catapano AL. ESC/EAS Guidelines for the management of dyslipidaemias: : the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). Eur Heart J. 2020;41(1):111-188.
3. Visseren FLJ, Mach F, Smulders YM. 2021 ESC Guidelines on cardiovascular disease prevention in clinical practice: developed by the Task Force for cardiovascular disease prevention in clinical practice with representatives of the European Society of Cardiology and 12 medical societies with the special contribution of the European Association of Preventive Cardiology (EAPC). Rev Esp Cardiol (Engl Ed). 2022;75(5):429-.